李然犀,范嘉祺,戴晗怡,朱齐丰,周道,王力涵,许烨铭,戚鑫瑞,刘先宝,王建安

• 1:浙江大学医学院附属第二医院心血管内科

摘要(Abstract)：

经导管二尖瓣置换术（TMVR）是治疗二尖瓣关闭不全的重要手段之一。左心室流出道梗阻（LVOTO）是TMVR术后的一种严重并发症，在术前正确识别LVOTO风险对于TMVR具有重要意义。这篇综述旨在回顾TMVR术前评估术后发生LVOTO风险的方法、危险因素及预防措施。

关键词(KeyWords)： 经导管二尖瓣置换术;左心室流出道梗阻

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李然犀,范嘉祺,戴晗怡,朱齐丰,周道,王力涵,许烨铭,戚鑫瑞,刘先宝,王建安

参考文献(References)：

• [1] Nkomo VT,Gardin JM,Skelton TN,et al. Burden of valvular heart diseases:a population-based study[J]. Lancet,2006,368(9540):1005-1011.
• [2] Coffey S, Roberts-Thomson R, Brown A, et al. Global epidemiology of valvular heart disease[J]. Nat Rev Cardiol,2021,18(12):853-864.
• [3] Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019:update from the GBD 2019 study[J]. J Am Coll Cardiol,2020,76(25):2982-3021.
• [4] Dziadzko V, Dziadzko M, Medina-Inojosa JR, et a l. Causes and mechanisms of isolated mitral regurgitation in the community:clinical context and outcome[J]. Eur Heart J,2019,40(27):2194-2202.
• [5] Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease[J]. Heart,2016,102(1):75-85.
• [6] Rossi A, Dini FL, Faggiano P, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy[J]. Heart,2011,97(20):1675-1680.
• [7] Dziadzko V, Clavel MA, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation:a community cohort study[J]. Lancet,2018,391(10124):960-969.
• [8] Mack M, Carroll JD, Thourani V, et al. Transcatheter mitral valve therapy in the United States:a report from the STS-ACC TVT Registry[J]. J Am Coll Cardiol,2021,78(23):2326-2353.
• [9] Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT registry of transcatheter aortic valve replacement[J]. J Am Coll Cardiol,2020,76(21):2492-2516.
• [10] Guerrero M, Urena M, Himbert D, et al. 1-Year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification[J]. J Am Coll Cardiol,2018,71(17):1841-1853.
• [11] Urena M, Vahanian A, S?ndergaard L. Patient selection for transcatheter mitral valve implantation:why is it so hard to find patients[J]? EuroIntervention,2018,14(Ab):Ab83-ab90.
• [12] Bapat V, Rajagopal V, Meduri C, et al. Early experience with new transcatheter mitral valve replacement[J]. J Am Coll Cardiol,2018,71(1):12-21.
• [13] Muller DWM, Farivar RS, Jansz P, et al. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation:a global feasibility trial[J]. J Am Coll Cardiol,2017,69(4):381-391.
• [14] Stone GW, Adams DH, Abraham WT, et al. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement:Part 2:endpoint definitions:a consensus document from the mitral valve academic research consortium[J]. J Am Coll Cardiol,2015,66(3):308-321.
• [15] Elliott PM, Anastasakis A, Borger MA, et al. 2014ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy:the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2014,35(39):2733-2779.
• [16] Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy:a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines[J]. J Am Coll Cardiol,2020,76(25):e159-e240.
• [17] Blanke P, Naoum C, Dvir D, et al. Predicting LVOT obstruction in transcatheter mitral valve implantation:concept of the Neo-LVOT[J]. JACC Cardiovasc Imaging,2017,10(4):482-485.
• [18] Blanke P, Naoum C, Webb J, et al. Multimodality imaging in the context of transcatheter mitral valve replacement:establishing consensus among modalities and disciplines[J].JACC Cardiovasc Imaging,2015,8(10):1191-1208.
• [19] Bolen MA, Popovic ZB, Dahiya A, et al. Prospective ECGtriggered, axial 4-D imaging of the aortic root, valvular,and left ventricular structures:a lower radiation dose option for preprocedural TAVR imaging[J]. J Cardiovasc Comput Tomogr,2012,6(6):393-398.
• [20] Reid A, Ben Zekry S, Turaga M, et al. Neo-LVOT and transcatheter mitral valve replacement:expert recommendations[J]. JACC Cardiovasc Imaging,2021,14(4):854-866.
• [21] Blanke P, Dvir D, Cheung A, et al. Mitral annular evaluation with CT in the context of transcatheter mitral valve replacement[J].JACC Cardiovasc Imaging,2015,8(5):612-615.
• [22] Blanke P, Dvir D, Cheung A, et al. A simplified D-shaped model of the mitral annulus to facilitate CT-based sizing before transcatheter mitral valve implantation[J]. J Cardiovasc Comput Tomogr,2014,8(6):459-467.
• [23] Wang DD, Eng MH, Greenbaum AB, et al. Validating a prediction modeling tool for left ventricular outflow tract(LVOT)obstruction after transcatheter mitral valve replacement(TMVR)[J]. Catheter Cardiovasc Interv,2018,92(2):379-387.
• [24] Yoon SH, Bleiziffer S, Latib A, et al. Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement[J]. JACC Cardiovasc Interv,2019,12(2):182-193.
• [25] El Sabbagh A, Al-Hijji M, Wang DD, et al. Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement in severe mitral annular calcification:an analysis of the transcatheter mitral valve replacement in mitral annular calcification global registry[J]. Circ Cardiovasc Interv,2021,14(10):e010854.
• [26] Halpern EJ, Gupta S, Halpern DJ, et al. Characterization and normal measurements of the left ventricular outflow tract by ECGgated cardiac CT:implications for disorders of the outflow tract and aortic valve[J]. Acad Radiol,2012,19(10):1252-1259.
• [27] Meduri CU, Reardon MJ, Lim DS, et al. Novel multiphase assessment for predicting left ventricular outflow tract obstruction before transcatheter mitral valve replacement[J]. JACC Cardiovasc Interv,2019,12(23):2402-2412.
• [28] El Sabbagh A, Eleid MF, Matsumoto JM, et al. Threedimensional prototyping for procedural simulation of transcatheter mitral valve replacement in patients with mitral annular calcification[J]. Catheter Cardiovasc Interv, 2018,92(7):E537-E549.
• [29] Alharbi Y, Otton J, Muller DWM, et al. Predicting t h e outcome of transcatheter mitral valve implantation using image-based computational models[J]. J Cardiovasc Comput Tomogr,2020,14(4):335-342.
• [30] Kohli K, Xu Y, Wei ZA, et al. TCT-102 assessing the risk of neo-left ventricular outflow tract obstruction in transcatheter mitral valve replacement:are we treating all the patients who can be treated[J]? J Am Coll Cardiol,2021,78(19):B43.
• [31] Bapat V, Pirone F, Kapetanakis S, et al. Factors influencing left ventricular outflow tract obstruction following a mitral valvein-valve or valve-in-ring procedure, part 1[J]. Catheter Cardiovasc Interv, 2015,86(4):747-760.
• [32] Khan JM, Lederman RJ, Devireddy CM, et al. LAMPOON to facilitate tendyne transcatheter mitral valve replacement[J].JACC Cardiovasc Interv,2018,11(19):2014-2017.
• [33] Khan JM, Trivedi U, Gomes A, et al.“Rescue” LAMPOON to treat transcatheter mitral valve replacement-associated left ventricular outflow tract obstruction[J]. JACC Cardiovasc Interv,2019,12(13):1283-1284.
• [34] Khan JM, Babaliaros VC, Greenbaum AB, et al. Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement[J]. J Am Coll Cardiol,2019,73(20):2521-2534.
• [35] Wang DD, Guerrero M, Eng MH, et al. Alcohol septal ablation to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement:First-in-man study[J].JACC Cardiovasc Interv,2019,12(13):1268-1279.
• [36] Khan JM, Rogers T, Babaliaros VC, et al. Predicting left ventricular outflow tract obstruction despite anterior mitral leaflet resection:the “Skirt NeoLVOT”[J]. JACC Cardiovasc Imaging,2018,11(9):1356-1359.